Press Release: MTI Staff was not involved in writing this content DUBLIN, Nov. 07, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that on November 6,...
Press Release: MTI Staff was not involved in writing this content Irvine, CA – November 7, 2024 – Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform for the treatment of drug refractory paroxysmal Atrial Fibrillation...
Press Release: MTI Staff was not involved in writing this content BURLINGAME, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) — Accumulus Synergy, Inc. (“Accumulus”), is revolutionizing the scalability of reliance pathways, enabling a recent submission from Sanofi to multiple national regulatory authorities (NRAs) around the globe. As industry...
Reposted from Matrix Requirements (August 24, 2024) Leveraging big data in medical device software is transforming the medtech industry, driving significant advancements in patient care and operational efficiency. By harnessing the power of big data, medical devices now offer real-time monitoring, predictive analytics, and personalized treatment...
The medtech industry continuously strives to deliver innovations that can enhance patient outcomes and improve their quality of life. But what happens if someone can’t access a medical device or diagnostic that can help them? Nearly 80% of U.S. counties are classified as healthcare deserts where obtaining proper care is challenging.1 To address this,...
Fifteen years ago, medical device reimbursement in Japan normally created a very profitable business for many device companies. For example, at that time, if the device company had 10% of its sales in Japan, it might have had 15% of its profits coming from Japan due to relatively high device reimbursement prices. Unfortunately, those days are over....
Készítse el saját hírfolyamát
Készen áll, hogy kipróbálja?
Indítson egy 14 napos próbaverziót, ehhez nincs szüksége bankártyára.